Acute Myeloid Leukemia (AML) with Monosomal Karyotype Is Characterized by Absence of NPM1 and FLT3 Mutations, Worse Clinical Outcome and Usually Falls within AML with Myelodysplasia-Related Changes (MRC)

被引：0
|
作者：
Weinberg, O. K. [1 ]
Seetharam, M. [1 ]
Ren, L. [1 ]
Ma, L. [1 ]
Seo, K. [1 ]
Zehnder, J. [1 ]
Gotlib, J. [1 ]
Arber, D. A. [1 ]
机构：
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1463
引用
收藏
页码：328A / 328A
页数：1
相关论文
共 50 条
  • [1] Acute Myeloid Leukemia (AML) with Monosomal Karyotype Is Characterized by Absence of NPM1 and FLT3 Mutations, Worse Clinical Outcome and Usually Falls within AML with Myelodysplasia-Related Changes (MRC)
    Weinberg, O. K.
    Seetharam, M.
    Ren, L.
    Ma, L.
    Seo, L.
    Zehnder, J.
    Gotlib, J.
    Arber, D. A.
    LABORATORY INVESTIGATION, 2010, 90 : 328A - 328A
  • [2] AML Patients with Monosomal Karyotype Are Characterized by Absence of NPM1 and FLT3 Mutations and Worse Clinical Outcome.
    Seetharam, Mahesh
    Weinberg, Olga K.
    Ren, Li
    Ma, Lisa
    Seo, Katie
    Zehnder, James L.
    Gotlib, Jason R.
    Arber, Daniel A.
    BLOOD, 2009, 114 (22) : 1035 - 1035
  • [3] NPM1 AND FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML)
    Aguiar, E.
    Amorim, M.
    Gomes, M. P.
    Guimaraes, P.
    Trigo, F.
    Guimaraes, J. E.
    HAEMATOLOGICA, 2012, 97 : 507 - 508
  • [4] Clinical significance of FLT3/ITD and NPM1 mutation in acute myeloid leukemia (AML).
    Suzuki, Rikio
    Onizuka, Makoto
    Shimada, Masako
    Iwaki, Yasunobu
    Kawada, Hiroshi
    Ogawa, Yoshiaki
    Hotta, Tomomitsu
    Ando, Kiyoshi
    BLOOD, 2006, 108 (11) : 188B - 188B
  • [5] Acute Myeloid Leukemia (AML) with Type A NPM1 Mutation Is More Frequently Associated with FLT3 Mutations Compared with AML with Non-Type A NPM1 Mutations
    Kanagal-Shamanna, R.
    Singh, R. R.
    Routbort, M. J.
    Ravandi, F.
    Kantarjion, H.
    Medeiros, L. J.
    Luthra, R.
    Patel, K. P.
    MODERN PATHOLOGY, 2014, 27 : 354A - 354A
  • [6] Clinical relevance of NPM1 and FLT3 mutations in AML patients
    Blau, O.
    Baldus, C. D.
    Graul, K.
    Sindram, A.
    Thiel, E.
    Blau, I. W.
    ONKOLOGIE, 2010, 33 : 234 - 234
  • [7] Acute Myeloid Leukemia (AML) with Type A NPM1 Mutation Is More Frequently Associated with FLT3 Mutations Compared with AML with Non-Type A NPM1 Mutations
    Kanagal-Shamanna, R.
    Singh, R. R.
    Routbort, M. J.
    Ravandi, F.
    Kantarjian, H.
    Medeiros, L. J.
    Luthra, R.
    Patel, K. P.
    LABORATORY INVESTIGATION, 2014, 94 : 354A - 354A
  • [8] NPM1 and FLT3 mutations in acute myeloid leukemia
    Nahajevszky, S.
    Tordai, A.
    Szitvasi, A.
    Meggyesi, N.
    Adam, E.
    Kozma, A.
    Lueff, S.
    Lovas, N.
    Kapas, B.
    Matrai, Z.
    Sipos, A.
    Masszi, T.
    Andrikovics, H.
    BLOOD REVIEWS, 2007, 21 : S110 - S111
  • [9] "Cup-like" blasts and NPM1 and FLT3 (ITD) mutations in acute myeloid leukemia (AML)
    Jain, Preetesh
    Vega-Vazquez, Francisco
    Faderl, Stefan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (01) : 3 - 3
  • [10] “Cup-like” blasts and NPM1 and FLT3 (ITD) mutations in acute myeloid leukemia (AML)
    Preetesh Jain
    Francisco Vega-Vazquez
    Stefan Faderl
    International Journal of Hematology, 2013, 98 : 3 - 3
12345